China Pharma Holdings, Inc. Reports First Quarter 2018 Financial Results
HAIKOU, China, May 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter ended...
CPHI to Hold First Quarter 2018 Earnings Conference Call On Tuesday May 15, 2018 at 8:30 a.m. ET
HAIKOU, China, May 8, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its first quarter 2018 earnings conference c...
China Pharma Holdings, Inc. Reports Fiscal Year 2017 Financial Results
HAIKOU, China, April 3, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the fiscal year ...
CPHI to Hold Fiscal Year 2017 Earnings Conference Call On Tuesday April 3, 2018 at 8:30 a.m. ET
HAIKOU CITY, China, March 22, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its fiscal year 2017 earnings confe...
China Pharma Holdings, Inc. Reports Third Quarter 2017 Financial Results
HAIKOU CITY, China, Nov. 15, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter...
CPHI to Hold Third Quarter 2017 Earnings Conference Call On Wednesday November 15, 2017 at 8:30 a.m. ET
HAIKOU CITY, China, Nov. 7, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its third quarter 2017 earnings confe...
China Pharma Holdings, Inc. Announces Notification of NYSE American Listing Deficiency
HAIKOU, China, Sept. 12, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) (the "Company") today announced receipt of notification (the "Deficiency Letter") from the NYSE AMERICAN LLC ("NYSE American") that the Company is not in compliance with certain NYSE American continued...
China Pharma Holdings, Inc. Reports Second Quarter 2017 Financial Results
HAIKOU CITY, China, Aug. 15, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter...
CPHI to Hold Second Quarter 2017 Earnings Conference Call On Tuesday August 15, 2017 at 8:30 a.m. ET
HAIKOU CITY, China, Aug. 8, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its second quarter 2017 earnings confe...
China Pharma Holdings, Inc.'s Wholly-owned Subsidiary Participated in PharmChina/API China Conferences
HAIKOU, China, May 17, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced its wholly-owned subsidiary, Hainan Helpso...
China Pharma Holdings, Inc. Reports First Quarter 2017 Financial Results
HAIKOU CITY, China, May 12, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter ...
CPHI to Hold First Quarter 2017 Earnings Conference Call On Friday May 12, 2017 at 8:30 a.m. ET
HAIKOU CITY, China, May 8, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its first quarter 2017 earnings confere...
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity
HAIKOU, China, June 17, 2011 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced that, in view of the unusual market activity in the common stock of China Pharma, the NYSE...
China Pharma Holdings, Inc. to Present at the Eighth Annual Piper Jaffray China Growth Conference in New York on May 17, 2011
HAIKOU, China, May 13, 2011 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceutical company in China, today announced that the Company's Chief Financial Officer, Mr. Frank Waung, has been invited to pre...
China Pharma Holdings, Inc. Reports First Quarter 2011 Financial Results
HAIKOU CITY, China, May 11, 2011 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the quarter ended March 31, 2011. First Quarter 2011 Highlights...
China Pharma Holdings, Inc. to Report First Quarter of Fiscal Year 2011 Financial Results on May 11, 2011
HAIKOU CITY, China, May 6, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release first quarter of year 2011 financial results b...
China Pharma Holdings, Inc. Reports Full Year 2010 Financial Results
HAIKOU CITY, China, March 3, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE Amex: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the year ended December 31, 2010. Full Year Highligh...
China Pharma Holdings, Inc. to Report Fiscal Year 2010 Financial Results on March 3, 2011
HAIKOU, China, Feb. 25, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its fiscal year 2010 financial results before the...
China Pharma Holdings, Inc. Announces Successful Completion of Clinical Trials of the Cholesterol-Lowering Drug, Rosuvastatin
HAIKOU CITY, China, Dec. 6, 2010 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced the completion of clinical trials of the cholesterol-lowering drug, rosuvastatin...
China Pharma Holdings, Inc. to Present at CLSA Emerging Markets Pharma Conference
HAIKOU, China, Dec. 1, 2010 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company's Chief Financial Officer, Mr. Frank Waung, is scheduled to present ...
